Understanding women's sexual health: A case-based approach

Mayo Clinic Proceedings

Volumn 83, Issue 12, 2008, Pages 1382-1387

  Marnach, Mary L ^a   Casey, Petra M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; INTERFERON; LIDOCAINE; METHYLPREDNISOLONE; TESTOSTERONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ACNE; CLINICAL FEATURE; FEMALE SEXUAL DYSFUNCTION; HIRSUTISM; HORMONAL THERAPY; HUMAN; REVIEW; SEXUAL BEHAVIOR; SEXUAL HEALTH; SLEEP APNEA SYNDROME; VAGINISM; VAGINITIS; VULVAR VESTIBULITIS; WOMEN'S HEALTH;

EID: 57349131095     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/83.12.1382     Document Type: Review

References (31)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors [published correction appears in JAMA. 1999;281(13):1174]. JAMA. 1999;281(6):537-544.
2. Laumann EO, Nicolosi A, Glasser DB, et al; GSSAB Investigators Group. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res. 2005;17(1):39-57.
3. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril. 2002;77(suppl 4):S42-S48.
4. Jacoby S. Sex in America. AARP. July & August 2005.
5. Masters WH, Johnson VE. Human Sexual Response. St Louis, MO: Little, Brown & Co; 1966.
6. Kaplan HS. Disorders of Sexual Desire and Other New Concepts and Techniques in Sex Therapy. New York, NY: Brunner/Mazel Publications; 1979.
7. Basson R. Female sexual response: the role of drugs in the management of sexual dysfunction [published correction appears in Obstet Gynecol. 2001;98(3):522]. Obstet Gynecol. 2001;98(2):350-353.
8. Basson R, Leiblum S, Brotto L, et al. Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol. 2003;24(4):221-229.
9. Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, Khan ZM. Antidepressant-induced sexual dysfunction. Ann Pharmacother. 2002;36(10):1577-1589.
10. Basson R, Berman J, Burnett A, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol. 2000;163(3):888-893.
11. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society. Menopause. 2007;14(3, pt 1):357-369.
12. Baker VL. Alternatives to oral estrogen replacement: transdermal patches, percutaneous gels, vaginal creams and rings, implants, and other methods of delivery. Obstet Gynecol Clin North Am. 1994;21(2):271-297.
13. Henriksson L, Stjernquist M, Boquist L, Alander U, Selinus I. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol. 1994;171(3):624-632.
14. Mandel FP, Geola FL, Meldrum DR, et al. Biological effects of various doses of vaginally administered conjugated equine estrogens in postmenopausal women. J Clin Endocrinol Metab. 1983;57(1):133-139.
15. Santen RJ, Pinkerton JV, Conaway M, et al. Treatment of urogenital atrophy with low-dose estradiol: preliminary results. Menopause. 2002;9(3):179-187.
16. Friedrich EG Jr. Vulvar vestibulitis syndrome. J Reprod Med. 1987;32(2):110-114.
17. Witkin SS, Gerber S, Ledger WJ. Differential characterization of women with vulvar vestibulitis syndrome. Am J Obstet Gynecol. 2002;187(3):589-594.
18. Traas MA, Bekkers RL, Dony JM, et al. Surgical treatment for the vulvar vestibulitis syndrome. Obstet Gynecol. 2006;107(2, pt 1):256-262.
19. Gaunt G, Good A, Stanhope CR. Vestibulectomy for vulvar vestibulitis. J Reprod Med. 2003;48(8):591-595.
20. Schover LR, Youngs DD, Cannata R. Psychosexual aspects of the evaluation and management of vulvar vestibulitis. Am J Obstet Gynecol. 1992;167(3):630-636.
21. Sinaki M, Merritt JL, Stillwell GK. Tension myalgia of the pelvic floor. Mayo Clin Proc. 1977;52(11):717-722.
22. Messelink B, Benson T, Berghmans B, et al. Standardization of terminology of pelvic floor muscle function and dysfunction: report from the Pelvic Floor Clinical Assessment Group of the International Continence Society. Neurourol Urodyn. 2005;24(4):374-380.
23. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005 Jul;90(7):3847-3853. Epub 2005 Apr 12.
24. Judd HL, Lucas WE, Yen S. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol. 1974;118(6):793-798.
25. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343(10):682-688.
26. Davis SR, van der Mooren M, van Lunsen R, et al. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Menopause. 2006;13(3):387-396.
27. Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab. 2005 Sep;90(9):5226-5233. Epub 2005 Jul 12.
28. Braunstein GD. Safety of testosterone treatment in postmenopausal women. Fertil Steril. 2007 Jul;88(1):1-17. Epub 2007 May 10.
29. Bachmann G, Bancroft J, Braunstein G, et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment. Fertil Steril. 2002;77(4):660-665.
30. Wierman ME, Basson R, Davis SR, et al. Androgen therapy in women: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2006 Oct;91(10):3697-3710. Epub 2006 Oct 3.
31. The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society. Menopause. 2005 Sep-Oct;12(5):496-511. Epub 2005 Sep 1.